Pancreatic Cancer Research

ResearcherSun Yat-sen UniversityActive in the last 2 years

Zhiqiang Fu

Matched on OpenAlex author ID A5083505888. Sources: OpenAlex.

Their work

Papers
26 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
63
Papers, trials and grants by year

2014: 1 paper · 2015: 5 papers · 2016: 1 paper · 2017: 3 papers · 2018: 4 papers · 2019: 2 papers · 2020: 2 papers · 2021: 2 papers · 2022: 2 papers · 2023: 1 paper · 2024: none · 2025: 2 papers · 2026: 1 paper

Papers 26

  1. Cancer-associated fibroblasts drive gemcitabine resistance in pancreatic cancer by promoting ferroptosis resistance via the PAX6/PAK3/SLC3A2 axis. Co-author DOI 10.1016/j.canlet.2026.218381↗
  2. Glycolysis reprogramming in CAFs promotes oxaliplatin resistance in pancreatic cancer through circABCC4 mediated PKM2 nuclear translocation. Co-author DOI 10.1038/s41419-025-07431-4↗
  3. N4-acetylcytidine modification of ITGB5 mRNA mediated by NAT10 promotes perineural invasion in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s13046-025-03362-2↗
  4. Extracellular vesicle-packaged circBIRC6 from cancer-associated fibroblasts induce platinum resistance via SUMOylation modulation in pancreatic cancer. Co-author DOI 10.1186/s13046-023-02854-3↗
  5. Corrigendum to "LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9" [Canc. Lett. 410 (2017) 68-81]. Co-author DOI 10.1016/j.canlet.2022.215836↗
  6. Correction: lncRNA-PLACT1 sustains activation of NF-κB pathway through a positive feedback loop with IκBα/E2F1 axis in pancreatic cancer. Co-author DOI 10.1186/s12943-022-01585-x↗
  7. Cancer-associated fibroblasts-mediated ATF4 expression promotes malignancy and gemcitabine resistance in pancreatic cancer via the TGF-β1/SMAD2/3 pathway and A… Co-author DOI 10.1038/s41419-021-03574-2↗
  8. Seven-gene signature on tumor microenvironment for predicting the prognosis of patients with pancreatic cancer. Co-author DOI 10.21037/gs-21-28↗
  9. lncRNA-PLACT1 sustains activation of NF-κB pathway through a positive feedback loop with IκBα/E2F1 axis in pancreatic cancer. Co-author DOI 10.1186/s12943-020-01153-1↗
  10. Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis. Co-author DOI 10.1186/s12943-020-01196-4↗
  11. Macrophage-expressed CD51 promotes cancer stem cell properties via the TGF-β1/smad2/3 axis in pancreatic cancer. Co-author DOI 10.1016/j.canlet.2019.06.005↗
  12. Excessive miR-25-3p maturation via N6-methyladenosine stimulated by cigarette smoke promotes pancreatic cancer progression. Co-author DOI 10.1038/s41467-019-09712-x↗
  13. FEZF1-AS1/miR-107/ZNF312B axis facilitates progression and Warburg effect in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41419-017-0052-1↗
  14. Tumor-associated macrophages promote progression and the Warburg effect via CCL18/NF-kB/VCAM-1 pathway in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s41419-018-0486-0↗
  15. Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa-miR-29b-3p in pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/jcmm.13351↗
  16. Anticancer effect of HOTTIP regulates human pancreatic cancer via the metabotropic glutamate receptor 1 pathway. Co-author DOI 10.3892/ol.2018.8870↗
  17. LncRNA HOTTIP modulates cancer stem cell properties in human pancreatic cancer by regulating HOXA9. Co-author DOI 10.1016/j.canlet.2017.09.019↗
  18. Endogenous miRNA Sponge LincRNA-ROR promotes proliferation, invasion and stem cell-like phenotype of pancreatic cancer cells. Co-author DOI 10.1038/cddiscovery.2017.4↗
  19. HIF-2α regulates non-canonical glutamine metabolism via activation of PI3K/mTORC2 pathway in human pancreatic ductal adenocarcinoma. Co-author DOI 10.1111/jcmm.13202↗
  20. Long non-coding RNA LOC389641 promotes progression of pancreatic ductal adenocarcinoma and increases cell invasion by regulating E-cadherin in a TNFRSF10A-rela… Co-author DOI 10.1016/j.canlet.2015.12.010↗
  21. The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer. Co-author DOI 10.1186/s12967-015-0442-z↗
  22. High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarcinoma. Co-author DOI 10.1186/s12967-015-0490-4↗
  23. Metabolic phenotypes in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0115153↗
  24. Inhibition of glutamine metabolism counteracts pancreatic cancer stem cell features and sensitizes cells to radiotherapy. First author DOI 10.18632/oncotarget.5150↗
  25. Expression profile of long non-coding RNAs in pancreatic cancer and their clinical significance as biomarkers. Co-author DOI 10.18632/oncotarget.5533↗
  26. Macrophage migration inhibitory factor is overexpressed in pancreatic cancer tissues and impairs insulin secretion function of β-cell. Co-author DOI 10.1186/1479-5876-12-92↗

Closest collaborators

The 25 strongest of 63 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shangyou Zheng · 19 shared papers, 2015–2026 · strength 1.88
  2. Quanbo Zhou · 18 shared papers, 2014–2025 · strength 1.47
  3. Rufu Chen · 14 shared papers, 2015–2025 · strength 1.22
  4. Huilin Ye · 15 shared papers, 2014–2022 · strength 1.07
  5. Zhihua Li · 7 shared papers, 2015–2026 · strength 0.74
  6. Yuming Luo · 7 shared papers, 2016–2023 · strength 0.69
  7. Changhao Chen · 7 shared papers, 2017–2022 · strength 0.69
  8. Rihua He · 3 shared papers, 2023–2025 · strength 0.64
  9. Xiaohui Zhao · 9 shared papers, 2015–2022 · strength 0.57
  10. Guolin Li · 7 shared papers, 2016–2021 · strength 0.54
  11. Yimin Liu · 9 shared papers, 2015–2018 · strength 0.49
  12. Lusheng Wei · 6 shared papers, 2017–2021 · strength 0.49
  13. Chonghui Hu · 3 shared papers, 2019–2025 · strength 0.48
  14. Leyi Huang · 3 shared papers, 2020–2025 · strength 0.48
  15. Yu Zhou · 2 shared papers, 2023–2025 · strength 0.40
  16. Huimou Chen · 3 shared papers, 2015–2026 · strength 0.39
  17. Wenzhu Li · 6 shared papers, 2015–2018 · strength 0.35
  18. Wenchao Gao · 7 shared papers, 2014–2016 · strength 0.30
  19. Yingxue Wang · 5 shared papers, 2015–2018 · strength 0.27
  20. Rufu Chen · 2 shared papers, 2020–2023 · strength 0.26
  21. Rufu Chen · 3 shared papers, 2019–2020 · strength 0.25
  22. Yue Zhao · 3 shared papers, 2017–2022 · strength 0.25
  23. Xiaofan Ren · 2 shared papers, 2020–2022 · strength 0.25
  24. Mingyang Liu · 2 shared papers, 2020–2022 · strength 0.25
  25. Yu Zhou · 5 shared papers, 2015–2018 · strength 0.25

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.